MedPath

Preventive Effect of Trimetazidine on Contrast Induced Nephropathy

Phase 3
Conditions
Contrast Induced Nephropathy (CIN).
Nephropathy induced by other drugs, medicaments and biological substances
Registration Number
IRCT20171004036555N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

30=Ejection Fraction>=45%
candidate for Elective Coronary Angiography

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with Contrast Induced Nephropathy (CIN). Timepoint: - creatinine measurement before intervention and 24,48 hours after intervention; NGAL(Neutrophil gelatinase-associated Lipocalin) before intervention and 12 hours after intervention. Method of measurement: -creatinine assay kit; NGAL assay kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath